Renal outcomes with efavirenz plus tenofovir disoproxil fumarate/emtricitabine versus other tenofovir disoproxil fumarate-containing antiretroviral regimens among HIV-infected veterans: a national study

被引：0
|
作者：
LaFleur, J. [1 ,2 ]
Bress, A. [1 ,2 ]
Esker, S. [3 ]
Crook, J. [2 ,4 ]
Nyman, H. [1 ,2 ]
Bedimo, R. [5 ,6 ]
Tebas, P. [7 ]
Rosenblatt, L. [3 ]
机构：
[1] Univ Utah, Dept Pharmacotherapy, Salt Lake City, UT USA
[2] Salt Lake City VA Hlth Care Syst, Salt Lake City, UT USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Univ Utah, Div Epidemiol, Salt Lake City, UT USA
[5] VA North Texas Hlth Care Syst, Dallas, TX USA
[6] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[7] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
ANTIVIRAL THERAPY | 2016年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
A60
引用
收藏
页码：A60 / A60
页数：1
相关论文
共 50 条
  • [1] Health Care Costs in a Cohort of HIV-Infected US Veterans Receiving Regimens Containing Tenofovir Disoproxil Fumarate/Emtricitabine
    Nelson, Richard E.
    Ma, Junjie
    Crook, Jacob
    Knippenberg, Kristin
    Nyman, Heather
    Paul, Damemarie
    Esker, Stephen
    LaFleur, Joanne
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (10): : 1052 - 1066
  • [2] Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients
    Gazzard, BG
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (06) : 793 - 802
  • [3] TENOFOVIR DISOPROXIL FUMARATE-CONTAINING REGIMENS IN PREGNANCY: REPORT FROM THE ANTIRETROVIRAL PREGNANCY REGISTRY
    Brown, Robert S.
    Goodwin, Diane
    Peschell, Kenneth J.
    Zhang, Sherry
    Fagan, Elizabeth A.
    [J]. HEPATOLOGY, 2009, 50 (04) : 497A - 497A
  • [4] Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection
    Cohen, Calvin
    Elion, Richard
    Ruane, Peter
    Shamblaw, David
    DeJesus, Edwin
    Rashbaum, Bruce
    Chuck, Steven L.
    Yale, Kitty
    Liu, Hui C.
    Warren, David R.
    Ramanathan, Srinivasan
    Kearney, Brian P.
    [J]. AIDS, 2011, 25 (06) : F7 - F12
  • [5] Efficacy of tenofovir alafenamide- or tenofovir disoproxil fumarate-containing regimens in adults with HIV-HBV coinfection
    Tabak, F.
    Yildiz, D. S.
    Zerdali, E.
    Kurt, F.
    Karaosmanoglu, H. Kumbasar
    Koc, M. Meric
    Gunduz, A.
    Oncul, A.
    Nakir, I. Yilmaz
    Unlu, E. Canpolat
    Aydin, O. Altuntas
    Mete, B.
    [J]. HIV MEDICINE, 2023, 24 : 645 - 646
  • [6] Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy
    Nishijima, Takeshi
    Kurosawa, Takuma
    Tanaka, Noriko
    Kawasaki, Yohei
    Kikuchi, Yoshimi
    Oka, Shinichi
    Gatanaga, Hiroyuki
    [J]. AIDS, 2016, 30 (10) : 1563 - 1571
  • [7] Cardiovascular Events in an Inner-City HIV Clinic and Relationship to Abacavir Versus Tenofovir Disoproxil Fumarate-Containing Antiretroviral Regimens
    Varriano, Brenda
    Crouzat, Frederic
    Sandler, Ina
    Smith, Graham
    Kovacs, Colin
    Gupta, Meenakshi
    Brunetta, Jason
    Fletcher, David
    Knox, David
    Merkley, Barry
    Chang, Benny
    Tilley, David
    Acsai, Megan
    Loutfy, Mona
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (01) : 44 - 53
  • [8] Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults
    Agbaji, Oche O.
    Abah, Isaac O.
    Ebonyi, Augustine O.
    Gimba, Zumnan M.
    Abene, Esla E.
    Gomerep, Simji S.
    Falang, Kakjing D.
    Anejo-Okopi, Joseph
    Agaba, Patricia A.
    Ugoagwu, Placid O.
    Agaba, Emmanuel I.
    Imade, Godwin E.
    Sagay, Atiene S.
    Okonkwo, Prosper
    Idoko, John A.
    Kanki, Phyllis J.
    [J]. JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2019, 18
  • [9] Efficacy and Safety of Dolutegravir With Emtricitabine and Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate, and Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate HIV Antiretroviral Therapy Regimens Started in Pregnancy oIMPAACT 2010/VESTEDTHORN: A Multicentre, Open-label, Randomised, Controlled, Phase 3 Trial
    Aquino, Marcella
    [J]. PEDIATRICS, 2021, 148 : S70 - S70
  • [10] Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
    Lockman, Shahin
    Brummel, Sean S.
    Ziemba, Lauren
    Stranix-Chibanda, Lynda
    McCarthy, Katie
    Coletti, Anne
    Jean-Philippe, Patrick
    Johnston, Ben
    Krotje, Chelsea
    Fairlie, Lee
    Hoffman, Risa M.
    Sax, Paul E.
    Moyo, Sikhulile
    Chakhtoura, Nahida
    Stringer, Jeffrey S. A.
    Masheto, Gaerolwe
    Korutaro, Violet
    Cassim, Haseena
    Mmbaga, Blandina T.
    Joao, Esau
    Hanley, Sherika
    Purdue, Lynette
    Holmes, Lewis B.
    Momper, Jeremiah D.
    Shapiro, Roger L.
    Thoofer, Navdeep K.
    Rooney, James F.
    Frenkel, Lisa M.
    Amico, K. Rivet
    Chinula, Lameck
    Currier, Judith
    [J]. LANCET, 2021, 397 (10281): : 1276 - 1292
12345